Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Nov 7;12:9355–9365. doi: 10.2147/OTT.S221228

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Wang et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Tan IIA enhances the pro-apoptotic effect of gefitinib in HCC827/gefitinib cells. (A, B) HCC827/gefitinib cells were treated with 40 nM OXA or/and 2 μM Tan IIA for 72 hrs. Apoptotic cells were measured by flow cytometry. (C, D) Expression level of active caspase 3 in HCC827/gefitinib cells was detected with Western blotting. *P<0.05, **P<0.01 compared with control group; ^##P<0.01 compared with 40 nM gefitinib group.